
Ivan A. Greene
Examiner (ID: 18341, Phone: (571)270-5868 , Office: P/1619 )
| Most Active Art Unit | 1619 |
| Art Unit(s) | 1619 |
| Total Applications | 712 |
| Issued Applications | 117 |
| Pending Applications | 109 |
| Abandoned Applications | 517 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17272999
[patent_doc_number] => 20210379197
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-09
[patent_title] => DUAL-TARGETING LIPID-POLYMER HYBRID NANOPARTICLES
[patent_app_type] => utility
[patent_app_number] => 17/228224
[patent_app_country] => US
[patent_app_date] => 2021-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8289
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17228224
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/228224 | DUAL-TARGETING LIPID-POLYMER HYBRID NANOPARTICLES | Apr 11, 2021 | Abandoned |
Array
(
[id] => 18404621
[patent_doc_number] => 20230165972
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-01
[patent_title] => CANCER THERAPY WITH MICROBUBBLES
[patent_app_type] => utility
[patent_app_number] => 17/915251
[patent_app_country] => US
[patent_app_date] => 2021-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15226
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17915251
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/915251 | CANCER THERAPY WITH MICROBUBBLES | Mar 29, 2021 | Pending |
Array
(
[id] => 18350610
[patent_doc_number] => 20230138721
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-04
[patent_title] => MESOPOROUS SILICA NANOPARTICLES, METHODS OF MAKING, AND METHODS OF USING
[patent_app_type] => utility
[patent_app_number] => 17/916115
[patent_app_country] => US
[patent_app_date] => 2021-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6153
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17916115
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/916115 | MESOPOROUS SILICA NANOPARTICLES, METHODS OF MAKING, AND METHODS OF USING | Mar 29, 2021 | Pending |
Array
(
[id] => 18404621
[patent_doc_number] => 20230165972
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-01
[patent_title] => CANCER THERAPY WITH MICROBUBBLES
[patent_app_type] => utility
[patent_app_number] => 17/915251
[patent_app_country] => US
[patent_app_date] => 2021-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15226
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17915251
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/915251 | CANCER THERAPY WITH MICROBUBBLES | Mar 29, 2021 | Pending |
Array
(
[id] => 18350610
[patent_doc_number] => 20230138721
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-04
[patent_title] => MESOPOROUS SILICA NANOPARTICLES, METHODS OF MAKING, AND METHODS OF USING
[patent_app_type] => utility
[patent_app_number] => 17/916115
[patent_app_country] => US
[patent_app_date] => 2021-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6153
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17916115
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/916115 | MESOPOROUS SILICA NANOPARTICLES, METHODS OF MAKING, AND METHODS OF USING | Mar 29, 2021 | Pending |
Array
(
[id] => 17198614
[patent_doc_number] => 20210338708
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-04
[patent_title] => METHOD FOR TREATMENT OF CORONAVIRUS INFECTION
[patent_app_type] => utility
[patent_app_number] => 17/205521
[patent_app_country] => US
[patent_app_date] => 2021-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6232
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17205521
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/205521 | METHOD FOR TREATMENT OF CORONAVIRUS INFECTION | Mar 17, 2021 | Abandoned |
Array
(
[id] => 18418393
[patent_doc_number] => 20230172851
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-08
[patent_title] => DEFORMABLE HYDROGEL PARTICLES AND PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT COMPRISING SAME
[patent_app_type] => utility
[patent_app_number] => 17/911626
[patent_app_country] => US
[patent_app_date] => 2021-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12377
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17911626
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/911626 | DEFORMABLE HYDROGEL PARTICLES AND PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT COMPRISING SAME | Mar 11, 2021 | Pending |
Array
(
[id] => 17384056
[patent_doc_number] => 20220031908
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-03
[patent_title] => Injectable Therapeutic Biocompatible Co-Polymers and Methods of Making and Using Same
[patent_app_type] => utility
[patent_app_number] => 17/200540
[patent_app_country] => US
[patent_app_date] => 2021-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9791
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17200540
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/200540 | Injectable Therapeutic Biocompatible Co-Polymers and Methods of Making and Using Same | Mar 11, 2021 | Abandoned |
Array
(
[id] => 17140047
[patent_doc_number] => 20210308058
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-07
[patent_title] => METHODS AND COMPOSITIONS RELATED TO SYNTHETIC NANOCARRIERS
[patent_app_type] => utility
[patent_app_number] => 17/199130
[patent_app_country] => US
[patent_app_date] => 2021-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20529
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17199130
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/199130 | METHODS AND COMPOSITIONS RELATED TO SYNTHETIC NANOCARRIERS | Mar 10, 2021 | Pending |
Array
(
[id] => 17065693
[patent_doc_number] => 20210267908
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-02
[patent_title] => PHARMACEUTICAL COMPOSITIONS OF RIVAROXABAN
[patent_app_type] => utility
[patent_app_number] => 17/188401
[patent_app_country] => US
[patent_app_date] => 2021-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4793
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17188401
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/188401 | PHARMACEUTICAL COMPOSITIONS OF RIVAROXABAN | Feb 28, 2021 | Abandoned |
Array
(
[id] => 17095273
[patent_doc_number] => 20210283064
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-16
[patent_title] => STABLE, BIOADHESIVE, AND DIFFUSION-RESTRICTIVE COACERVATE
[patent_app_type] => utility
[patent_app_number] => 17/185269
[patent_app_country] => US
[patent_app_date] => 2021-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17297
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17185269
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/185269 | STABLE, BIOADHESIVE, AND DIFFUSION-RESTRICTIVE COACERVATE | Feb 24, 2021 | Pending |
Array
(
[id] => 18226634
[patent_doc_number] => 20230065628
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => Droplet Formation and Particle Morphology
[patent_app_type] => utility
[patent_app_number] => 17/759592
[patent_app_country] => US
[patent_app_date] => 2021-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41247
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -287
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17759592
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/759592 | Droplet Formation and Particle Morphology | Feb 18, 2021 | Pending |
Array
(
[id] => 17096967
[patent_doc_number] => 20210284758
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-16
[patent_title] => POLYMER-CYCLIC MOLECULE STRUCTURE AND METHOD FOR PRODUCING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/178808
[patent_app_country] => US
[patent_app_date] => 2021-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19607
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17178808
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/178808 | POLYMER-CYCLIC MOLECULE STRUCTURE AND METHOD FOR PRODUCING THE SAME | Feb 17, 2021 | Abandoned |
Array
(
[id] => 18211643
[patent_doc_number] => 20230057906
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-23
[patent_title] => MULTIPLE COMPONENT GRAFTS FOR TREATING TISSUE DEFECTS AND METHODS FOR MAKING AND USING SAME
[patent_app_type] => utility
[patent_app_number] => 17/792546
[patent_app_country] => US
[patent_app_date] => 2021-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9305
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17792546
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/792546 | MULTIPLE COMPONENT GRAFTS FOR TREATING TISSUE DEFECTS AND METHODS FOR MAKING AND USING SAME | Jan 13, 2021 | Pending |
Array
(
[id] => 16930693
[patent_doc_number] => 20210196582
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-01
[patent_title] => METAL EXTRACTION SHEET, MASK PACK INCLUDING SAME AND METHOD FOR MANUFACTURING THE METAL EXTRACTION SHEET
[patent_app_type] => utility
[patent_app_number] => 17/136251
[patent_app_country] => US
[patent_app_date] => 2020-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4767
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17136251
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/136251 | METAL EXTRACTION SHEET, MASK PACK INCLUDING SAME AND METHOD FOR MANUFACTURING THE METAL EXTRACTION SHEET | Dec 28, 2020 | Abandoned |
Array
(
[id] => 18181579
[patent_doc_number] => 20230042308
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-09
[patent_title] => GOLDEN LIPID NANOPARTICLES FOR GENE THERAPY
[patent_app_type] => utility
[patent_app_number] => 17/783022
[patent_app_country] => US
[patent_app_date] => 2020-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14484
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17783022
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/783022 | GOLDEN LIPID NANOPARTICLES FOR GENE THERAPY | Dec 21, 2020 | Pending |
Array
(
[id] => 18181579
[patent_doc_number] => 20230042308
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-09
[patent_title] => GOLDEN LIPID NANOPARTICLES FOR GENE THERAPY
[patent_app_type] => utility
[patent_app_number] => 17/783022
[patent_app_country] => US
[patent_app_date] => 2020-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14484
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17783022
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/783022 | GOLDEN LIPID NANOPARTICLES FOR GENE THERAPY | Dec 21, 2020 | Pending |
Array
(
[id] => 18140807
[patent_doc_number] => 20230014648
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-19
[patent_title] => Determining Capsule Specificity for Specific Cell Types
[patent_app_type] => utility
[patent_app_number] => 17/786678
[patent_app_country] => US
[patent_app_date] => 2020-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2471
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17786678
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/786678 | Determining Capsule Specificity for Specific Cell Types | Dec 16, 2020 | Abandoned |
Array
(
[id] => 18140807
[patent_doc_number] => 20230014648
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-19
[patent_title] => Determining Capsule Specificity for Specific Cell Types
[patent_app_type] => utility
[patent_app_number] => 17/786678
[patent_app_country] => US
[patent_app_date] => 2020-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2471
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17786678
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/786678 | Determining Capsule Specificity for Specific Cell Types | Dec 16, 2020 | Abandoned |
Array
(
[id] => 16883612
[patent_doc_number] => 20210169807
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-10
[patent_title] => PHARMACEUTICAL COMPOSITION COMPRISING AN ATYPICAL ANTIPSYCHOTIC AGENT AND METHOD FOR THE PREPARATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/106625
[patent_app_country] => US
[patent_app_date] => 2020-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4008
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17106625
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/106625 | PHARMACEUTICAL COMPOSITION COMPRISING AN ATYPICAL ANTIPSYCHOTIC AGENT AND METHOD FOR THE PREPARATION THEREOF | Nov 29, 2020 | Abandoned |